Triumeq

Active Ingredient(s): Abacavir Sulfate + Dolutegravir + Lamivudine
FDA Approved: * August 22, 2014
Pharm Company: * VIIV HLTHCARE
Category: HIV / AIDS

Abacavir/dolutegravir/lamivudine (brand name Triumeq) is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. It is a combination of three medications with different and complementary mechanisms of action: 600mg abacavir (reverse transcriptase inhibitor), 50mg dolutegravir (integrase inhibitor) and 300mg lamivudine (nucleoside analog reverse transcriptase inhibitor). The medication was developed by ViiV Healthcare and was approved for use in the United States and... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Triumeq Oral Tablet, Film Coated
NDC: 49702-231
Labeler:
Viiv Healthcare Company
Triumeq Oral Tablet, Film Coated
NDC: 50090-1606
Labeler:
A-s Medication Solutions
Triumeq Oral Tablet, Film Coated
NDC: 54569-6569
Labeler:
A-s Medication Solutions

Related Brands

Drugs with the same active ingredients